These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30903490)

  • 1. Expression of Aβ42, τ-Protein, p16, p53 in Buccal Epithelium: Prospects for Use in the Diagnostics of Alzheimer's Disease and Rate of Aging.
    Zuev VA; Dyatlova AS; Lin'kova NS; Kvetnaya TV
    Bull Exp Biol Med; 2019 Mar; 166(5):676-679. PubMed ID: 30903490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
    Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
    Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease.
    Schirinzi T; Di Lazzaro G; Sancesario GM; Colona VL; Scaricamazza E; Mercuri NB; Martorana A; Sancesario G
    J Neural Transm (Vienna); 2017 Dec; 124(12):1621-1625. PubMed ID: 28866757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
    Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
    FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults.
    Paternicò D; Galluzzi S; Drago V; Bocchio-Chiavetto L; Zanardini R; Pedrini L; Baronio M; Amicucci G; Frisoni GB
    Alzheimers Dement; 2012 Nov; 8(6):520-7. PubMed ID: 22677492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells.
    Hooper C; Meimaridou E; Tavassoli M; Melino G; Lovestone S; Killick R
    Neurosci Lett; 2007 May; 418(1):34-7. PubMed ID: 17399897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.
    Sjögren M; Davidsson P; Wallin A; Granérus AK; Grundström E; Askmark H; Vanmechelen E; Blennow K
    Dement Geriatr Cogn Disord; 2002; 13(2):112-8. PubMed ID: 11844893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular markers of Alzheimer disease early diagnostic: investigation perspectives of peripheral tissues.].
    Paltsev MA; Zuev VA; Kozhevnikova EO; Linkova NS; Kvetnaia TV; Polyakova VO; Kvetnoy IM
    Adv Gerontol; 2017; 30(6):809-817. PubMed ID: 29608821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive function in very old men does not correlate to biomarkers of Alzheimer's disease.
    Velickaite V; Giedraitis V; Ström K; Alafuzoff I; Zetterberg H; Lannfelt L; Kilander L; Larsson EM; Ingelsson M
    BMC Geriatr; 2017 Sep; 17(1):208. PubMed ID: 28886705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do astrocytes collaborate with neurons in spreading the "infectious" aβ and Tau drivers of Alzheimer's disease?
    Dal Prà I; Chiarini A; Gui L; Chakravarthy B; Pacchiana R; Gardenal E; Whitfield JF; Armato U
    Neuroscientist; 2015 Feb; 21(1):9-29. PubMed ID: 24740577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of Alzheimer's Disease in Primary Visual Cortex in Normal Aging in Mice.
    Hernández-Zimbrón LF; Perez-Hernández M; Torres-Romero A; Gorostieta-Salas E; Gonzalez-Salinas R; Gulias-Cañizo R; Quiroz-Mercado H; Zenteno E
    Biomed Res Int; 2017; 2017():3706018. PubMed ID: 29138750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.
    Sauvée M; DidierLaurent G; Latarche C; Escanyé MC; Olivier JL; Malaplate-Armand C
    J Alzheimers Dis; 2014; 41(2):377-86. PubMed ID: 24614902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer's Disease.
    Moosavi B; Mousavi B; Macreadie IG
    J Alzheimers Dis; 2015; 47(1):9-16. PubMed ID: 26402750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease.
    Krishnan S; Rani P
    Biol Trace Elem Res; 2014 May; 158(2):158-65. PubMed ID: 24682919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
    Hansson O; Zetterberg H; Buchhave P; Londos E; Blennow K; Minthon L
    Lancet Neurol; 2006 Mar; 5(3):228-34. PubMed ID: 16488378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.
    Alcolea D; Martínez-Lage P; Sánchez-Juan P; Olazarán J; Antúnez C; Izagirre A; Ecay-Torres M; Estanga A; Clerigué M; Guisasola MC; Sánchez Ruiz D; Marín Muñoz J; Calero M; Blesa R; Clarimón J; Carmona-Iragui M; Morenas-Rodríguez E; Rodríguez-Rodríguez E; Vázquez Higuera JL; Fortea J; Lleó A
    Neurology; 2015 Aug; 85(7):626-33. PubMed ID: 26180139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease.
    Mollenhauer B; Bibl M; Trenkwalder C; Stiens G; Cepek L; Steinacker P; Ciesielczyk B; Neubert K; Wiltfang J; Kretzschmar HA; Poser S; Otto M
    J Neural Transm (Vienna); 2005 Jul; 112(7):933-48. PubMed ID: 15937638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteins Involved in Endocytosis Are Upregulated by Ageing in the Normal Human Brain: Implications for the Development of Alzheimer's Disease.
    Alsaqati M; Thomas RS; Kidd EJ
    J Gerontol A Biol Sci Med Sci; 2018 Mar; 73(3):289-298. PubMed ID: 28655199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease.
    Pan C; Korff A; Galasko D; Ginghina C; Peskind E; Li G; Quinn J; Montine TJ; Cain K; Shi M; Zhang J
    J Alzheimers Dis; 2015; 45(3):709-19. PubMed ID: 25613100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-dependent SIRT6 expression protects Aβ42-induced DNA damage.
    Jung ES; Choi H; Song H; Hwang YJ; Kim A; Ryu H; Mook-Jung I
    Sci Rep; 2016 May; 6():25628. PubMed ID: 27156849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.